Similarly, Kato et al. identified Euchromatic Histone Lysine Methyltransferase 2 (EHMT2) as a promoter of melanoma pathogenesis through the inhibition of DKK1 via H3K9 mono- and di-methylation. This evidence concerns the gene EHMT2 and melanoma.